SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 424B5 - Prospectus [Rule 424(b)(5)]:
SEC Accession No. 0001193125-21-148189
Filing Date
2021-05-03
Accepted
2021-05-03 17:14:31
Documents
5

Document Format Files

Seq Description Document Type Size
1 424B5 d171722d424b5.htm 424B5 535905
2 GRAPHIC g171722g01a00.jpg GRAPHIC 31373
3 GRAPHIC g171722g02q02.jpg GRAPHIC 133332
4 GRAPHIC g171722g09a00.jpg GRAPHIC 148612
5 GRAPHIC g171722g45d84.jpg GRAPHIC 34924
  Complete submission text file 0001193125-21-148189.txt   1008646
Mailing Address 60 AVENUE ROCKEFELLER BATIMENT ADENINE LYON I0 69008
Business Address 60 AVENUE ROCKEFELLER BATIMENT ADENINE LYON I0 69008 011-33-4-78-74-44-38
Erytech Pharma S.A. (Filer) CIK: 0001624422 (see all company filings)

IRS No.: 000000000 | State of Incorp.: I0 | Fiscal Year End: 1231
Type: 424B5 | Act: 33 | File No.: 333-248953 | Film No.: 21884641
SIC: 2836 Biological Products, (No Diagnostic Substances)